Diabetes

Top 5 tips for managing diabetes on Valentine’s Day.

The key to keeping blood sugar levels safely maintained may be found within intracellular changes to some brain cells.

Internalizing weight bias can lead to unhealthy behaviors and high levels of triglycerides.

Evidence-based medicine may improve treatment for diabetes.

Patients with severe mental illnesses avoidably die much sooner than general population.

Obesity blamed for the tendency of diabetes patients to develop osteoarthritis.

Physical exercise has long been shown to have positive benefits for patients with type 1 and type 2 diabetes.

Top news of the day from across the health care landscape.

Top news of the day from across the health care landscape.

Eli Lilly’s type 2 diabetes drug, Trulicity (dulaglutide), has updated its label, discussing use in combination with basal insulin for adults with type 2 diabetes to achieve greater blood sugar control.

Obesity-related diabetes is transforming into a global health crisis that is no longer limited to developed countries.

The STAND program prevents avoidable hospitalizations by providing type 1 diabetes information in 3 sessions.

Common diabetes drug changes the biology of cancer cells.

Diabesity is quickly transforming into a global health crisis that is no longer limited to developed countries.

Disruptions in circadian rhythm can alter the release of insulin and glucose, causing diabetes.

Metformin shown to alter metabolic pathways of cancer cells.

Overweight patients who experience an inflammatory response are at a higher risk for diabetes.

Adults who have HIV are more likely to develop diabetes than the general population, a study published in BMJ Open Diabetes Research & Care estimates.

Researchers at Kaiser Permanente suggest that triglyceride-lowering therapy in patients with type 2 diabetes can decrease medical costs in a new study published in the American Journal of Cardiology.

Recommendations for screening, diagnosis, management, and treatment for the specific forms are also included in the position paper.

A new partnership between academia and pharmaceutical industries aims to improve diabetes treatment.

Top news of the day from across the health care landscape.

New index more precisely determines the probability of reducing liver fat during lifestyle interventions.

The microbiome and inflammatory signature differs in patients with type 1 diabetes.

Diabetes-related outcomes significantly differ by state and insurance type.